$AMTX Cashflow Statement | Understand Stock

$AMTX

$1.26 -$0.04 (3.08%) Close

$AMTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Share-based compensation
Stock issued for services
TEC debt extension, waiver fees, promissory notes fees added to debt
Capital expenditures in accounts payable
Fair value of stock issued to a related party for guarantee fees
Fair value of warrants issued to lender for debt issuance costs
Fair value of stock issued to lender
Fair value of warrants issued for capital expenditures
Depreciation
Bad debt expense
Change in fair value of stock appreciation rights
Intangibles and other amortization expense
Debt related fees and amortization expense
Accretion and other expenses of Series A preferred units
Gain (Loss) on asset disposals
Warrants issued for working capital agreement
Loss on asset disposals
Gain on debt/liability extinguishment
Gain on litigation
Loss on lease termination
Provision for excess and obsolete inventory
Deferred tax (benefit) expense
Loss on impairment of intangibles

Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses
Tax credit sale receivable
Other assets
Accounts payable
Accrued interest expense and fees, net of interest paid
Other liabilities
Net cash provided by (used in) operating activities
Investing activities:
Capital expenditures
Grant proceeds received for capital expenditures
Net cash used in investing activities
Financing activities:
Proceeds from borrowings
Repayments of borrowings
TEC debt renewal and waiver fee payments
Grant proceeds received for capital expenditures
Lender debt renewal and waiver fee payments
Payments on Series A preferred financing
Payments on finance leases
Proceeds from sales of common stock
Proceeds from the exercise of stock options
Proceeds from Series A preferred units financing
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents and restricted cash
Net change in cash and cash equivalents and restricted cash for period
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period

Supplemental disclosures of cash flow information, cash paid:
Cash paid for interest
Income taxes paid
Supplemental disclosures of cash flow information, non-cash transactions:
Settlement of AP via issuance of RSAs
Settlement of Accounts Payable via issuance of common stock
Subordinated debt extension fees added to debt
Debt fees added to revolving lines
Fair value of warrants issued to subordinated debt holders
Lender debt extension, waiver, and other fees added to debt
Cumulative capital expenditures in accounts payable and accruals
Payment of debt added to revolving lines
Operating lease liabilities arising from obtaining right of use assets
Financing lease liabilities arising from obtaining right of use assets
Unpaid capital expenditures in construction financing
Issuance of equity to pay off accounts payable

Comments